However, considering risk stratification for identifying high-risk patients in Brugada syndrome, SCN5A mutation, VF inducibility by EP study and pharmacologic challenge were not predictive factors of life-threatening arrhythmic events [17]. The gene discussed is SCN5A; the disease is Brugada syndrome.